Iovance Biotherapeutics, Inc. - Common Stock (IOVA)
Iovance Biotherapeutics, Inc. - Common Stock (IOVA) last closed at $8.70 (as of 2026-09-03). On Shishin's four-engine momentum model it scored 70/100, flagged by the Suzaku engine (Extended) on its most recent scan appearance (2026-09-03). It has surfaced in 29 daily scans since 2026-07-20. The figures below are research data, the Shishin Score and the momentum, trend, and volatility indicators the engines observe, not investment advice.
Price updates daily; the engine read reflects IOVA's most recent scan appearance. Shishin's live daily signals are published each morning on the rankings board.
IOVA is in Shishin's signals for 2026-09-03, flagged by the Suzaku engine, with a composite momentum score of 70/100.
IOVA's Shishin Score has climbed 33 points (from 37 to 70/100) across its recent scans, momentum-of-score is building.
What is IOVA's Shishin momentum score?
As of 2026-09-03, IOVA scores 70/100 on Shishin's four-engine composite, flagged by the Suzaku engine. The score blends momentum, trend, and volatility indicators on a 0 to 100 scale.
Is IOVA showing a momentum setup?
IOVA's current setup state is "Extended." This describes what the engines observe in the chart structure, it is a data classification, not a recommendation to buy or sell.
Which Shishin engine flags IOVA?
Most recently the Suzaku engine. Each of the four guardians is tuned for a different market regime.
How often has IOVA appeared in Shishin scans?
IOVA has appeared in 29 daily scans since 2026-07-20. Recurring appearances indicate a persistent setup; one-off appearances are more transient.
How is the Shishin Score calculated?
The Shishin Score (0 to 100) is a weighted blend of momentum (multi-horizon returns), trend (moving-average stack, distance from MAs), and volatility/liquidity (ADR, ATR, dollar volume) indicators, scored per the engine active for the current market regime.
Research data, not investment advice. Shishin publishes what its systematic engines observe; it does not recommend buying or selling any security, and is not a registered investment adviser or broker-dealer. See our risk disclosure.